Orthotopic vascularized right lung transplantation in the mouse  by Li, Wenjun et al.
Li et al Cardiothoracic TransplantationOrthotopic vascularized right lung transplantation in the mouseWenjun Li, MD,a Seiichiro Sugimoto, MD, PhD,a Jiaming Lai, MD,a G. Alexander Patterson, MD,a
Andrew E. Gelman, PhD,a,b Alexander S. Krupnick, MD,a and Daniel Kreisel, MD, PhDa,bFrom th
versit
Dr Krei
Blood
(1K0
(1R0
Disclos
Receive
publi
Address
and I
sity in
0022-52
Copyrig
doi:10.1Objectives:Orthotopic left lung transplantation in the mouse, as recently developed by our laboratory, represents
a physiologic model for studies in transplantation biology. However, because of the limited overall respiratory
contribution of the murine left lung, left lung transplant recipients remain healthy despite immune-mediated graft
necrosis. We sought to develop a lung transplantation model in which animal survival depends on graft function.
Methods:Orthotopic vascularized right lung transplantations using cuff techniques were performed in syngeneic
and allogeneic strain combinations. Grafts were assessed histologically or functionally by measuring arterial
blood gases from 7 to 28 days after transplantation. In a parallel set of experiments, syngeneic and immunosup-
pressed allogeneic hosts underwent a left pneumonectomy 2 weeks after right lung transplantation, with assess-
ment of graft function 1 week later.
Results:We performed 40 right lung transplantations, with a survival rate of 87.5%. Syngeneic grafts remain free
of inflammation as far as 28 days after transplantation. On day 7, arterial oxygen levels in syngeneic recipients
(481  90 mm Hg) are equivalent to those in naive mice (503  59 mm Hg) after left hilar occlusion. Alterna-
tively, allogeneic grafts develop histologic evidence of acute rejection, and arterial oxygen levels are significantly
decreased after left hilar clamping (53.3 10.3 mmHg). Both syngeneic and immunosuppressed allogeneic right
lung recipients tolerate a left pneumonectomy.
Conclusions: Right lung transplantation followed by left pneumonectomy represents the first survival model of
vascularized lung transplantation in the mouse and will therefore allow for the design of novel studies in exper-
imental lung transplantation. (J Thorac Cardiovasc Surg 2010;139:1637-43)Physiologic animal models have been instrumental for the
advancement of clinical lung transplantation. To this end,
technical refinements and immunosuppressive studies in ca-
nine models of pulmonary autotransplantation or allotrans-
plantation have paved the way for the first successful
human lung transplantations.1-3 Introduction of cuff tech-
niques has allowed for the widespread use of orthotopic
lung transplantation in the rat.4 Undoubtedly, important in-
sights into lung transplantation biology have been gained
by using the rat model. However, the paucity of transgenic
and knockout strains in the rat limits the use of this model
for the design of mechanistic studies. Extending microsurgi-
cal techniques established in the rat model, our laboratory
was the first to describe a method for orthotopic vascularized
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Xhave reported important differences between requirements
for allograft rejection in the lung compared with other or-
gans.6 Notably, there exist marked similarities between ob-
servations in murine and human lung allografts, pointing
out the potential translational value of the murine model.5,7
Other murine transplantation models have clearly defined
indicators of graft rejection, such as cessation of heart beat in
the case of vascularized cardiac transplantation, animal
death in the case of kidney transplantation with removal of
the recipient’s native kidneys, or sloughing and necrosis of
the graft in the case of skin transplantation.8-10 One limita-
tion of the orthotopic left lung transplantation model in the
mouse is that recipient animals survive and appear healthy
even after alloimmune-mediated necrosis of their allo-
grafts.11 Therefore graft assessment relies on histologic ex-
amination of the transplanted left lung. We sought to
develop a murine lung transplantation model in which sur-
vival depends on the function of the transplanted lung.
Here we took advantage of the fact that the right murine
lung is markedly larger than the left lung. The right murine
lung, which is composed of 4 lobes, accounts for approxi-
mately 70% of the total lung volume.12 Here, for the first
time, we report the development of a technique for ortho-
topic vascularized right lung transplantation in the mouse.
Syngeneic recipients have fully functional grafts and are
able to survive a left pneumonectomy, thereby providing
the first description of a survival model for experimental
lung transplantation in the mouse.diovascular Surgery c Volume 139, Number 6 1637
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Animals
Male inbred C57BL/6 (H-2b; B6) and BALB/c (H-2d) mice were pur-
chased from Jackson Laboratories (Bar Harbor, Me). Animals weighing
22 to 28 grams were used as donors, and mice weighing 26 to 30 grams
were used as recipients. Syngeneic transplantations were performed in the
B6 / B6 strain, and allogeneic transplantations were performed in the
B6/ BALB/c and BALB/c/ B6 strain combinations. Some allogeneic
transplants received treatment with anti-CD40 ligand antibody (MR1;
250 mg administered intraperitoneally, day 0) and cytotoxic T-lympho-
cyte–associated antigen-4-immunoglobulin (200 mg administered intraperi-
toneally, day 2). All animal procedures were approved by the Animal
Studies Committee at Washington University School of Medicine. Animals
received humane care in compliance with the ‘‘Guide for the care and use of
laboratory animals’’ prepared by the National Academy of Sciences and
published by the National Institutes of Health and the ‘‘Principles of labora-
tory animal care’’ formulated by the National Society for Medical Research.Donor Procedure
Donor mice are anesthetized with an intraperitoneal injection of ket-
amine (50 mg/kg) and xylazine (10 mg/kg), intubated with a 20-gauge an-
giocatheter through a tracheostomy, and then attached to a rodent ventilator.
After injection of 100 units of heparin into the penile vein, the chest is ex-
posed through a median laparosternotomy. The right atrium, left atrium, and
inferior vena cava are incised to vent the heart, and subsequently, 3 mL of
cold low-potassium dextran glucose solution is injected into the main pul-
monary artery to flush the lungs. The trachea is ligated after the lungs are
inflated to end-tidal volume with room air, and the heart–lung block is ex-
cised. The right lung is then prepared for the placement of cuffs. A 22-gauge
angiocatheter is used for the pulmonary artery, a 20-gauge angiocatheter is
used for pulmonary veins, and an 18-gauge angiocatheter is used for the
right mainstem bronchus.
Because of anatomic differences between the right and the left lungs in
the mouse, we were forced to modify our previously described technique for
the donor portion of the left lung transplantation.5 The pulmonary vein is
located anterior to the pulmonary artery, and the right mainstem bronchus
courses posterior to the pulmonary artery. The anatomic arrangement of
these hilar structures necessitates a careful dissection to avoid damage. Im-
portantly, although the left lung is made up of a single lobe, the right lung is
composed of 4 lobes, namely the apical lobe, the azygous lobe, the cardiac
lobe, and the diaphragmatic lobe (Figure 1, A). The pulmonary veins drain-
ing the lobes of the right lung converge in close proximity to the left atrium,
resulting in a relatively short right pulmonary vein. Therefore the length of
the cuff for the right pulmonary vein (0.3 mm excluding the extension han-
dle) needs to be shorter than for left lung transplantation (0.6 mm; Figure 1,
B). The length of the cuff for the pulmonary artery is 0.6 mm. After intro-
duction of these structures through the cuffs and everting their ends, the
cuffs are secured with a circumferential 10–0 nylon ligature. Of note, as pre-
viously described for the left lung transplantation procedure, we cuff the
bronchus at the time of implantation. The length of the bronchial cuff is
0.6 mm. The donor procedure takes approximately 40 minutes. The donor
lung is stored in low-potassium dextran glucose solution at 4 C until im-
plantation.FIGURE 1. A, Right lung anatomy: 1, apical lobe; 2, azygous lobe; 3, car-
diac lobe; 4, diaphragmatic lobe. B, Donor pulmonary vein (PV) after place-
ment of the cuff. C, Implantation of donor right lung is initiated by insertion
of the cuffed donor pulmonary artery (PA) into the recipient PA. Only the in-
ferior branch is used for later insertion of the cuffed donor PV.Br, Bronchus.Recipient Procedure
Recipient mice are anesthetized with an intraperitoneal injection of ket-
amine (50 mg/kg) and xylazine (10 mg/kg), intubated orotracheally with
a 20-gauge intravenous catheter, and then placed in a left lateral decubitus
position. A right thoracotomy is performed, a portion of the third rib is ex-
cised to enhance exposure, and a chest retractor is placed. Dissection is ini-
tiated in the superior portion of the pulmonary hilum, where the right
mainstem bronchus is gently freed from the pulmonary artery. Of note,
the right mainstem bronchus is markedly shorter than the left mainstem1638 The Journal of Thoracic and Cardiovascular Surgery c June 2010
Li et al Cardiothoracic Transplantationbronchus. Therefore during dissection of the right mainstem bronchus, spe-
cial attention needs to be directed toward avoiding injury to the left bron-
chus. The right bronchus is occluded close to the carina with a slipknot
(8–0 silk ligature), leading to a collapse of the right lung, which facilitates
the subsequent dissection. To further improve exposure, we then excise the
diaphragmatic lobe and attach a clamp to the remainder of the right lung for
lateral retraction. The pulmonary artery is dissected free from the pulmonary
vein and then occluded with a slipknot (10–0 silk ligature). The superior
branch of the pulmonary vein is divided between two 10–0 silk ties. We
then occlude the inferior branch of the pulmonary vein with a slipknot
(8–0 silk ligature) close to its confluence with the superior branch. The re-
cipient pulmonary artery is incised, and the cuffed donor pulmonary artery
is inserted and secured as previously described for the left lung transplanta-
tion procedure (Figure 1, C).13 The donor lung is rotated medially to expose
the recipient right mainstem bronchus. We then incise the recipient bron-
chus, insert the cuffed donor bronchus, and secure it with a circumferential
ligature (10–0 nylon). Only the inferior branch of the recipient pulmonary
vein is used for insertion of the cuffed donor pulmonary vein. The pulmo-
nary venous anastomosis is also secured with a circumferential ligature
(10–0 nylon). The recipient right lung is excised, and the slipknots on the
pulmonary veins, pulmonary artery, and bronchus are released to reperfuse
the lung. The recipient procedure takes approximately 70 to 80minutes. The
cold ischemic period lasts approximately 50 minutes, and the implantation
of the donor lung, during which the graft is covered with an ice cold sponge,
takes approximately 15 minutes.
Left Pneumonectomy
Two weeks after right lung transplantation, mice are placed in a right lat-
eral decubitus position and a left thoracotomy is performed. The chest is en-
tered through the third intercostal space. The left hilar structures are mass
ligated with a 6–0 silk tie, and the left lung is excised. A piece of Gelfoam
(Pfizer, New York, NY) is placed into the left chest cavity before closure to
stabilize the mediastinum. Postoperatively, mice are maintained on 100%
oxygen for 30 minutes.
Histology
At the time of death, lung grafts were harvested, inflation fixed in form-
aldehyde, embedded in paraffin, sectioned, and stained with hematoxylin
and eosin.
Functional Graft Assessment
After a 4-minute period of occlusion of the left pulmonary hilum, arterial
blood was drawn from the left ventricle while mice were ventilated with
a fraction of inspired oxygen of 1.0. Blood gases were measured with an iS-
TAT Portable Clinical Analyzer (iMale STAT Corp, East Windsor, NJ).
Statistical Analysis
Statistical analysis was performed with the Student’s t test. Oxygen
levels are expressed as the mean  standard error of the mean.
T
XRESULTS
Macroscopic and Microscopic Appearance of
Syngeneic and Allogeneic Grafts
A total of 40 right lung transplantations were performed,
with a survival rate of 87.5%. Five animals died intraoper-
atively of bleeding (n¼ 3) or in the immediate postoperative
period because of pneumothoraces (n ¼ 2). Syngeneic B6
grafts were ventilated at 7 days (n ¼ 10) and appeared
grossly normal up to 28 days (n ¼ 16) after transplantation
(Figure 2). On histologic examination, these grafts had noThe Journal of Thoracic and Carevidence of inflammation and were comparable with lungs
not undergoing surgical intervention. On the other hand, al-
logeneic BALB/c/ B6 right lung grafts were not venti-
lated at 7 days after transplantation and had histologic
evidence of acute rejection with perivascular cuffing and
peribronchiolar mononuclear infiltrates (n ¼ 3, Figure 3).
B6/ BALB/c (n ¼ 3) right lung grafts were also acutely
rejected 7 days after transplantation (data not shown).
Functional Assessment of Right Lung Grafts
To assess the grafts functionally, we compared arterial ox-
ygen levels in naive B6 mice and syngeneic B6/ B6 right
lung transplant recipients 7 days after engraftment after oc-
clusion of the left pulmonary hilum.We found no significant
differences between oxygen levels in these 2 groups after ei-
ther 4 minutes (PaO2 of 503 59mmHg in naive B6mice [n
¼ 4] and PaO2 of 481  90 mm Hg in B6/ B6 right lung
transplant recipients [n¼ 4), P>.1) or 10 minutes of left hi-
lar occlusion (PaO2 of 399.2 16.9 mmHg in naive B6mice
[n ¼ 3] and PaO2 of 362.5  6.9 mm Hg in B6/ B6 right
lung recipients [n¼ 3], P>.1), indicating that the syngeneic
right lung transplants are functional (Figure 4). However,
oxygen levels were significantly lower in allogeneic
BALB/c/ B6 right lung recipients compared with those
in both naive B6 mice and syngeneic right lung recipients
after 4 minutes of left hilar clamping (53.3  10.3 mm Hg,
n¼ 3; P<.01 compared with syngeneic transplant recipients
and naive mice).
Right Lung Transplantation Followed by Left
Pneumonectomy
We measured arterial oxygen levels in syngeneic B6 right
lung transplant recipients 7 days after a left pneumonec-
tomy. There were no statistically significant differences be-
tween these mice and naive B6 mice 7 days after a left
pneumonectomy (PaO2 of 534  61 mm Hg in naive B6
mice after left pneumonectomy [n ¼ 3] and PaO2 of 461 
67 mm Hg in B6/ B6 right lung transplant recipients after
left pneumonectomy [n ¼ 3], P ¼ 0.23; Figure 5). We have
previously reported that in left lung transplants perioperative
blockade of CD40/CD40 ligand and B7/CD28 costimula-
tory pathways prevents graft necrosis, and grafts stay venti-
lated for time periods exceeding 100 days.11 BALB/c/ B6
right lung transplant recipients that received this regimen
tolerated a left pneumonectomy. Their arterial oxygen levels
7 days after left pneumonectomy were 373.1 16.3 mm Hg
(n ¼ 3; P> .1 vs syngeneic B6 right lung transplant recipi-
ents after left pneumonectomy and P<.05 vs naive B6 mice
after left pneumonectomy).
DISCUSSION
Outcomes after lung transplantation are markedly worse
than those after transplantation of all other organs. Develop-
ment of new experimental models in the mouse will bediovascular Surgery c Volume 139, Number 6 1639
FIGURE 2. Gross appearance and histology (hematoxylin and eosin stain, original magnification 1003) of a right B6 lung not undergoing surgical inter-
vention (A and B), as well as a right B6 lung 7 (C and D; n ¼ 10) and 28 (E and F; n ¼ 3) days after transplantation into a B6 recipient. Tx, Right lung graft.
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Xcritical for the design of novel investigations in lung trans-
plant biology. To this end, we and others have recently re-
ported microsurgical techniques for orthotopic left lung
transplantation in the mouse.5,13,14 Heterotopic murine tra-
cheal transplantation has been widely used as a model for
lung transplantation.15 However, this model is not likely to
mirror immunologic and nonimmunologic events that lead
to failure of vascularized human lung grafts. Unlike human1640 The Journal of Thoracic and Cardiovascular Surlung transplants, tracheal transplants are not vascularized
and are not exposed to the external environment. Airway ep-
ithelial cells in tracheal allografts undergo apoptosis, leading
to fibroproliferation and occlusion of the lumen. In stark
contrast, we have recently reported that airway epithelial
cells remain intact, maintain differentiation markers, and
also upregulate antiapoptotic proteins in nonimmunosup-
pressed vascularized allografts that have undergonegery c June 2010
FIGURE 3. Gross appearance (A) and histology (hematoxylin and eosin stain, original magnification 1003; B) 7 days after transplantation of a right BALB/
c lung into a B6 recipient. Results are representative of 3 independent experiments.
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Xextensive vascular necrosis.11 These observations suggest
that airway epithelial cells might be able to protect them-
selves and that insults in addition to the alloimmune re-
sponse might be necessary to initiate changes in airway
epithelial cells that eventually lead to the fibrotic changes
seen in bronchiolitis obliterans.
We have observed several similarities between vascular-
ized murine lung transplants and human lung transplants.
Histologic changes of acute rejection in murine lungs are
analogous to those observed in human lungs.5 Moreover,
compared with orthotopic lung transplantation models in
the rat, important advantages of the murine model are the
wider availability of transgenic and knockout strains, as
well as reagents for cellular and molecular analysis. The mu-
rine model has already allowed us to gain some new insight
into requirements for acute lung rejection. Unlike the case
for other organs, CD8þ T cells outnumber CD4þ T cells in
both murine and human lungs that undergo acute rejec-
tion.7,16 Notably, CD4þT cells are not necessary for the ac-
tivation of alloreactive CD8þ T cells and for the acute
rejection of murine lung grafts.7 Clinical observations in
combined heart–lung transplantations in the 1980s have re-
vealed that lung rejection is initiated at earlier time points
than cardiac rejection.17 A recent study by our group has
provided a potential mechanism for this observation.6 Al-
though secondary lymphoid organs are critically important
for the rejection of other organs, including the heart and
skin, alloreactive T cells can be primed locally within lung
grafts.18 In fact, we have observed clustering of recipient
T cells around graft-resident dendritic cells at early time
points after engraftment, indicating that the lung allograft
represents a suitable environment for the activation of allor-
eactive T cells.
In this study we have modified techniques that we have
previously described for transplantation of the left lung.5,13
Because of anatomic differences, we found right lungThe Journal of Thoracic and Cartransplantation to be technically more challenging, which
also resulted in longer operative times for both the donor
and recipient procedures. Therefore ischemic times are lon-
ger for right compared with left lung transplantations when
both donor and recipient operations are performed consecu-
tively by the same surgeon. Specifically, the right pulmonary
vein is markedly shorter than the left pulmonary vein. We
found it technically impossible to insert the cuffed donor
pulmonary vein into the main right pulmonary vein of the re-
cipient animal or perform separate inferior and superior pul-
monary venous anastomoses, as has been previously
described in the rat.19 Therefore we opted to ligate the supe-
rior pulmonary venous branch and use the inferior branch for
insertion of the donor vessel. We did not experience pulmo-
nary venous outflow obstruction with this technique.
Bilateral lung transplantation in mice would most closely
mirror bilateral sequential lung transplantation in human
subjects, which is currently the most commonly used tech-
nique worldwide. There are no published reports of success-
ful bilateral lung transplantation in the rat, and in our hands
attempts at bilateral sequential lung transplantation in the
mouse have resulted in intraoperative animal death. Al-
though further developments of microsurgical techniques
might eventually result in successful bilateral lung transplan-
tation in rodents, we had to rely on the removal of the native
left lung to limit the recipient’s lung function to the trans-
planted graft.
Unlike previous descriptions for left pneumonectomies in
naive mice, we found it critical to place a piece of Gelfoam
into the left chest cavity of right lung recipients at the time of
the left pneumonectomy to prevent mediastinal shifting,
which in our hands led to the death of the animal in the im-
mediate postoperative period.20 Similar to a previous report
of right lung transplantation followed by left pneumonec-
tomy in the rat, we performed the left pneumonectomy after
a 2-week recovery period after the transplantation of thediovascular Surgery c Volume 139, Number 6 1641
FIGURE 5. There were no statistically significant differences in PaO2
levels between wild-type B6 mice (n ¼ 3) and B6 recipients of syngeneic
right B6 lung transplants 7 days after left pneumonectomy (n ¼ 3, P> .1).
Lt PNX, Left pneumonectomy; Syn Rt Txþ Lt PNX, right syngeneic lung
transplantation plus left pneumonectomy. PaCO2 levels were 35.2  2.7
and 28 6mm Hg for the Lt PNX and Syn Rt TxþLt PNX groups, respec-
tively. pH was 7.38 0.02 and 7.35 0.02 for the Lt PNX and Syn Rt Txþ
Lt PNX groups, respectively. Base deficits were 2.9  1.8 and 8.5  2.6 for
the Lt PNX and Syn Rt TxþLt PNX groups, respectively. PaO2 levels in
MR1- and cytotoxic T lymphocyte–associated antigen–immunoglobulin–
treated BALB/c / B6 right lung recipients after left pneumonectomy
(n ¼ 3; Allo Rt Txþ Lt PNX) were 373.1  16.3mm Hg (P> .1 vs the
Syn Rt TxþLt PNX group and P< .05 vs the Lt PNX group). PCO2 levels
were 28.3  5.9, pH was 7.36  0.03, and the base deficit was 8.3  1.6.FIGURE 4. A, There were no statistically significant differences in arterial
PaO2 levels between wild-type (WT) B6 mice (n ¼ 3) and B6 recipients of
syngeneic right B6 lungs 7 days after transplantation (n¼ 3) after 10minutes
of left hilar occlusion. B, PaO2 levels were significantly lower in allogeneic
BALB/c/ B6 right lung transplant recipients (n¼ 3) than in either synge-
neic B6/ B6 right lung transplant recipients (n ¼ 4) or naive B6 mice
(n¼ 4) after a 4-minute period of left hilar occlusion (*P<.01). After 4min-
utes of left hilar occlusion, the pH was 7.37 0.02 for naive B6 mice, 7.29
 0.02 for B6/ B6 transplant recipients, and 7.19 0.02 for BALB/c/
B6 transplant recipients. The PCO2 was 33.3 2.1mmHg for naive B6mice,
46.9  3.9 for B6/ B6 transplant recipients, and 46.7  2.6 for BALB/c
/ B6 transplant recipients. The base deficit was 3.3  0.7 for naive B6
mice, 3.6  1.4 for B6 / B6 transplant recipients, and 8.7  0.8 for
BALB/c/ B6 transplant recipients.
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weeks after right lung transplantation resulted in death of
the animals, which might be due to transiently impaired graft
function caused by reperfusion injury.21 A better under-
standing of molecular mechanisms contributing to ische-
mia/reperfusion-related graft dysfunction might allow right
lung recipients to tolerate a left pneumonectomy at earlier
time points.
To our knowledge, there exist no reports of successful
right pneumonectomies in the mouse, which is likely related
to an inability of the left lung to compensate for the sudden
loss of 70% of overall lung function. To this end, left lung
transplant recipients did not survive a right pneumonectomy,
even after prolonged recovery periods. Allogeneic right lung1642 The Journal of Thoracic and Cardiovascular Surrecipients undergoing acute graft rejection were alive at 7
days after transplantation but displayed respiratory distress.
It is possible that a gradual loss of right graft function in
these nonimmunosuppressed allogeneic recipients might al-
low for the development of some compensatory mechanisms
by the native left lung.22
It is important to point out that compensatory growth of
the right lung has been well described after left pneumonec-
tomies in mice. This process involves expansion of multiple
cell populations, such as endothelial and epithelial cells, and
results in complete restoration of the original lung volume.23
Compensatory lung growth is associated with the rapid
upregulation of multiple genes and transcription factors.24
Therefore processes regulating compensatory growth of
the graft can influence right lung graft function after a left
pneumonectomy and should be taken into consideration
when designing studies and interpreting results with this
model. Similarly, compensatory lung growth might affect
graft function after lobar transplantation in the pediatric pop-
ulation.25
In conclusion, this is the first description of vascularized
aerated transplantation of the right lung in the mouse. Histo-
pathologic changes observed in syngeneic and allogeneic
grafts are virtually identical to those that we have reported
after transplantation of the left lung.5 An important advan-
tage of right lung transplantation is that right lung recipientsgery c June 2010
Li et al Cardiothoracic Transplantationtolerate a left pneumonectomy where graft failure can result
in animal death. Therefore because we have demonstrated
that right allograft recipients that are treated with costimula-
tory blockade can tolerate a left pneumonectomy, this model
might be valuable for long-term studies evaluating graft sur-
vival in immunosuppressed hosts. Thus this model repre-
sents an important addition to the armamentarium in
experimental lung transplantation.
We thank Arlene Ligori for the medical illustrations.
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